SCCM Neuroscience Section/X
Nov 6, 2025, 07:08
Study Finds NOACs as Safe and Effective as Warfarin in CVST
SCCM Neuroscience Section posted on X:
”Use of new oral anticoagulants (NOACs) in cerebral venous sinus thrombosis (CVST) has similar efficacy and safety compared to warfarin treatment.
NOACs treatment may improve clinical prognosis in pts with CVST.”
Read the study here.
Title: Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis: A Propensity Score Matching Study and Inverse Probability Weighting
Authors: Kai Liu, Mengmeng Zhang, Jiawei Zhao, Qinqin Dai, Yuan Gao, Shen Li, Lu Zhao, Yuming Xu, Bo Song
Stay informed with Hemostasis Today.
Anticoagulation
Bo Song
cerebral venous sinus thrombosis
CVST
Direct Oral Anticoagulants
DOACs
Health
Hematology
Hemostasis
Hemostasis Today
Jiawei Zhao
Kai Liu
Lu Zhao
Medicine
Mengmeng Zhang
New OralAnticoagulants
NOACs
Qinqin Dai
SCCM Neuroscience Section
Shen Li
thrombosis
Venous Thrombosis
Warfarin
Yuan Gao
Yuming Xu
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD